Overview of the National Cancer Institute's activities related to exposure of the public to fallout from the Nevada Test Site.
The Department of Health and Human Services (DHHS) was directed by Congress to assess the risk of thyroid cancer from 131I associated with fallout from the atmospheric testing of nuclear weapons at the Nevada Test Site. The National Cancer Institute (NCI) was requested by DHHS to address Public Law 97-414, Section 7 (a), which directs DHHS to "(1) conduct scientific research and prepare analyses necessary to develop valid and credible assessments of the risks of thyroid cancer that are associated with thyroid doses of Iodine 131; (2)...develop...methods to estimate the thyroid doses of Iodine 131 that are received by individuals from nuclear bomb fallout; (and) (3)...develop...assessments of the exposure to Iodine 131 that the American people received from the Nevada atmospheric nuclear bomb tests." In addition, the University of Utah, under contract with the NCI, is carrying out a study to determine if the incidence of thyroid disease and leukemia among identified populations in Utah may be related to exposure from fallout originating at the Nevada Test Site.
Wachholz
B W
BW
Radiation Effects Branch, National Cancer Institute, Bethesda, MD 20892.
D004781:Environmental Exposure; D006801:Humans; D007953:Leukemia, Radiation-Induced / Q000453:epidemiology; D009505:Nevada / Q000453:epidemiology; D009689:Nuclear Warfare; D011847:Radioactive Fallout; D013959:Thyroid Diseases / Q000453:epidemiology / Q000209:etiology; D014481:United States; D014483:United States Dept. of Health and Human Services; D014589:Utah / Q000453:epidemiology
D011847:Radioactive Fallout